Strata Skin Sciences, Inc.
SSKN
$2.59
-$0.03-1.15%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 10.21% | -0.62% | 2.24% | -10.74% | -18.04% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 10.21% | -0.62% | 2.24% | -10.74% | -18.04% |
| Cost of Revenue | -1.77% | -10.47% | -11.04% | 15.57% | 3.57% |
| Gross Profit | 19.91% | 7.13% | 14.34% | -29.81% | -29.89% |
| SG&A Expenses | 6.19% | 26.24% | -11.55% | -13.98% | -11.08% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 0.98% | 10.38% | -12.64% | -5.02% | -5.94% |
| Operating Income | 68.37% | -168.78% | 75.23% | -11.72% | -963.43% |
| Income Before Tax | -20.10% | -101.52% | 96.86% | -18.80% | -3,906.19% |
| Income Tax Expenses | -84.78% | -- | -- | -- | -246.03% |
| Earnings from Continuing Operations | -18.53% | -101.52% | 96.86% | -18.80% | -2,271.25% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -18.53% | -101.52% | 96.86% | -18.80% | -2,271.25% |
| EBIT | 68.37% | -168.78% | 75.23% | -11.72% | -963.43% |
| EBITDA | 608.20% | -149.64% | 243.07% | -37.93% | -91.62% |
| EPS Basic | 0.54% | -74.20% | 96.88% | -18.13% | -2,249.67% |
| Normalized Basic EPS | 57.78% | -74.22% | 57.20% | -18.12% | -1,533.71% |
| EPS Diluted | 0.54% | -74.20% | 96.88% | -18.13% | -2,249.67% |
| Normalized Diluted EPS | 57.78% | -74.22% | 57.20% | -18.12% | -1,533.71% |
| Average Basic Shares Outstanding | 19.17% | 15.69% | 0.51% | 0.57% | 0.87% |
| Average Diluted Shares Outstanding | 19.17% | 15.69% | 0.51% | 0.57% | 0.87% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |